# Lilly’s weight-loss pill improves sleep apnea in late-stage trial

https://mins.news/en/item/135925

- Reuters, 2026-11-09 17:00 UTC
- Health
- Original: https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-weight-loss-pill-meets-main-goal-late-stage-sleep-apnea-study-2026-11-09/?link_source=ta_bluesky_link&taid=6af1fc476e5c8a0001b1da8a

> Eli Lilly said on Monday that its oral weight-loss drug Foundayo significantly reduced sleep-time breathing interruptions among obese adults with moderate-to-severe obstructive sleep apnea, meeting the main goal of a late-stage study.
